Loading stock…

Temenos AG (TEMN) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

TEMNTemenos

Revenue FY25$1.1B

GROWTH RATING↗

AVERAGE51 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+5%5

Revenue, next 1Y+7%5

Revenue, next 3Y, CAGR+7%5

Revenue, next 5Y, CAGR+7%6

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+14%7

EPS growth, FY27E+10%7

EPS growth, FY28E+10%7

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow in step with sales (EPS about 10%/yr vs revenue 7%/yr).

WATCH

A mid-pack grower, ahead of 51% of companies worldwide.

Revenue is set to grow 7%/yr over the next 3 years, in line with the market.5/10

Revenue grew 5%/yr over the last 3 years and is set to keep growing around 7%/yr.

Over five years revenue is set to grow 7%/yr, ahead of 50% of companies worldwide.6/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

TEMNTemenos

Total return Current26.7%

Price return Current15.0%

MOMENTUM RATING↗

WEAK25 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-3%5

YTD return-15%3

MID & LONG-TERM▾SCORE

% of 52-week high78%5

1-year return+2%5

3-year return+10%3

5-year return-42%2

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

It's up 2% over the past year, but 22% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-6%) and over three months (-3%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+10% over three years and -42% over five), behind 70% of the market.

The stock is underperforming so far this year (-15%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Temenos AG. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

TEMNTemenos

Revenue FY25$1.1B

GROWTH RATING↗

AVERAGE51 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+5%5

Revenue, next 1Y+7%5

Revenue, next 3Y, CAGR+7%5

Revenue, next 5Y, CAGR+7%6

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+14%7

EPS growth, FY27E+10%7

EPS growth, FY28E+10%7

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow in step with sales (EPS about 10%/yr vs revenue 7%/yr).

WATCH

A mid-pack grower, ahead of 51% of companies worldwide.

Revenue is set to grow 7%/yr over the next 3 years, in line with the market.5/10

Revenue grew 5%/yr over the last 3 years and is set to keep growing around 7%/yr.

Over five years revenue is set to grow 7%/yr, ahead of 50% of companies worldwide.6/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

TEMNTemenos

Total return Current26.7%

Price return Current15.0%

MOMENTUM RATING↗

WEAK25 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-3%5

YTD return-15%3

MID & LONG-TERM▾SCORE

% of 52-week high78%5

1-year return+2%5

3-year return+10%3

5-year return-42%2

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

It's up 2% over the past year, but 22% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-6%) and over three months (-3%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+10% over three years and -42% over five), behind 70% of the market.

The stock is underperforming so far this year (-15%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Temenos AG. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Temenos AG

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Temenos AG. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Temenos AG. Get the full investment case.

Premium